Exiqon AS:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Exiqon AS - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6408
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:デンマーク
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Exiqon AS (Exiqon), a subsidiary of Qiagen NV, is a medical device company that develops, manufactures and markets molecular diagnostic test products. The company provides product categories such as microRNA research, incRNA research, mRNA research, DNA research, custom oligos and other reagent products, among others. It offers microRNA research products such as RNA isolation kits, microRNA sequencing kits, microRNA microarray analysis, universal RT microRNA PCR, microRNA detection probes, ISH detection probes and ISH kits and functional analysis, among others. Exiqon provides services such as RNA isolation services, microRNA PCR service, sequencing, xploreRNA, microRNA ISH services and custom pharma service, among others. The company’s products find applications in isolation, microarray analysis, northern blotting, real-time PCR, in situ hybridization, functional analysis and SNP detection, among others. It operates in Denmark and the US. Exiqon is headquartered in Copenhagen, Denmark.

Exiqon AS – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Exiqon AS, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Exiqon AS, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Exiqon AS, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Exiqon AS, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Exiqon AS, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Exiqon AS, Medical Equipment, Deal Details 10
Transgenomic Expands Licensing Agreement with Exiqon 10
Equity Offering 11
Exiqon Completes Private Placement Of Shares For US$2.6 Million 11
Debt Offering 12
Exiqon Raises USD5.8 Million in Private Placement of 9.25% Note 12
Exiqon Completes Private Placement Of Bonds For US$3 Million 13
Acquisition 14
Qiagen Acquires Exiqon for up to USD102.4 Million 14
Exiqon AS – Key Competitors 16
Exiqon AS – Key Employees 17
Exiqon AS – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Exiqon AS, Medical Equipment, Key Facts 2
Exiqon AS, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Exiqon AS, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Exiqon AS, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Exiqon AS, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Exiqon AS, Deals By Market, 2012 to YTD 2018 8
Exiqon AS, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Transgenomic Expands Licensing Agreement with Exiqon 10
Exiqon Completes Private Placement Of Shares For US$2.6 Million 11
Exiqon Raises USD5.8 Million in Private Placement of 9.25% Note 12
Exiqon Completes Private Placement Of Bonds For US$3 Million 13
Qiagen Acquires Exiqon for up to USD102.4 Million 14
Exiqon AS, Key Competitors 16
Exiqon AS, Key Employees 17
Exiqon AS, Subsidiaries 18

List of Figures
Exiqon AS, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Exiqon AS, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Exiqon AS, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Exiqon AS, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Exiqon AS, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Exiqon AS, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Exiqon AS, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Exiqon AS, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Exiqon AS:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Massachusetts General Hospital:企業のM&A・事業提携・投資動向
    Massachusetts General Hospital - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Massachusetts General Hospital Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • Aspect Imaging Inc:医療機器:M&Aディール及び事業提携情報
    Summary Aspect Imaging Inc (Aspect Imaging) is a medical device company that develops and manufactures magnetic resonance imaging systems. The company’s products comprise wristview medical systems, preclinical, process control, oil and gas analyzers, NMR, materials MRI and software. It offers precli …
  • ION Geophysical Corporation (IO)-石油・ガス分野:企業M&A・提携分析
    Summary ION Geophysical Corporation (ION) is a provider of seismic solutions. It offers advanced seismic data acquisition equipment, software, and seismic processing and planning services to the global oil and gas industry. The company acquires, process and interpret seismic data from seismic survey …
  • Oncolytics Biotech Inc (ONC):製薬・医療:M&Aディール及び事業提携情報
    Summary Oncolytics Biotech Inc (Oncolytics) is a development stage biopharmaceutical company which focuses on the discovery and development of oncolytic viruses for the treatment of cancer. The company’s lead product, Reolysin, a formulation of the human reovirus, is indicated for the treatment of l …
  • deCODE genetics:企業のM&A・事業提携・投資動向
    deCODE genetics - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's deCODE genetics Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Coherent Inc (COHR):企業の財務・戦略的SWOT分析
    Coherent Inc (COHR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • The Maryland Technology Development Corp:企業のM&A・事業提携・投資動向
    The Maryland Technology Development Corp - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's The Maryland Technology Development Corp Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed …
  • Cognizant Technology Solutions Corporation:戦略・SWOT・企業財務分析
    Cognizant Technology Solutions Corporation - Strategy, SWOT and Corporate Finance Report Summary Cognizant Technology Solutions Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • Fiskars Corporation:企業の戦略・SWOT・財務情報
    Fiskars Corporation - Strategy, SWOT and Corporate Finance Report Summary Fiskars Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Bharat Sanchar Nigam Ltd:企業の戦略的SWOT分析
    Bharat Sanchar Nigam Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Abu Dhabi Commercial Bank P.J.S.C.:戦略・SWOT・企業財務分析
    Abu Dhabi Commercial Bank P.J.S.C. - Strategy, SWOT and Corporate Finance Report Summary Abu Dhabi Commercial Bank P.J.S.C. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • AB Electrolux:企業の戦略・SWOT・財務情報
    AB Electrolux - Strategy, SWOT and Corporate Finance Report Summary AB Electrolux - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Merck KGaA:企業のM&A・事業提携・投資動向
    Merck KGaA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Merck KGaA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • KAZ Minerals PLC:企業の戦略・SWOT・財務情報
    KAZ Minerals PLC - Strategy, SWOT and Corporate Finance Report Summary KAZ Minerals PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Bladt Industries AS:電力:M&Aディール及び事業提携情報
    Summary Bladt Industries AS (Bladt Industries) is an alternative energy company that offers large scale and complex steel structures. The company offers manufacturing and distribution of steel structures. It offers products for offshore foundations, suctions anchors, offshore substations, modules, t …
  • Telus Corp (T):企業の財務・戦略的SWOT分析
    Telus Corp (T) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • TechnipFMC Plc (FTI):企業の財務・戦略的SWOT分析
    TechnipFMC Plc (FTI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Nuvo Pharmaceuticals Inc (NRI):企業の財務・戦略的SWOT分析
    Summary Nuvo Pharmaceuticals Inc (Nuvo), formerly Nuvo Research Inc, is a healthcare company that offers portfolio of commercial products and pharmaceutical manufacturing capabilities. The company’s product portfolio includes pennsaid, heated lidocaine and tetracaine patches. Its products deliver dr …
  • Enteris BioPharma Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Enteris BioPharma Inc (Enteris) is a biotechnology company that offers formulation solutions based on proprietary drug delivery technologies. The company’s product candidate includes oral leuprolide tablet, which is developed for endometriosis in women. Its other product candidates comprise …
  • Nokia Corporation:戦略・SWOT・企業財務分析
    Nokia Corporation - Strategy, SWOT and Corporate Finance Report Summary Nokia Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆